<DOC>
	<DOCNO>NCT02490683</DOCNO>
	<brief_summary>This study test effect Luna Rich X© Reliv Now© placebo pill powder ( control ) blood lipid . It also explore potential effect dietary supplement inflammation marker biological anthropometric measure . The study intervention 30 week length . Twenty four subject 2 cardiometabolic risk factor randomize participate study .</brief_summary>
	<brief_title>Effects Soy Based Dietary Supplements Cardiometabolic Risk Factors .</brief_title>
	<detailed_description>Primary Objective To test effect Luna Rich X© , Reliv Now© serum lipid select inflammatory oxidative parameter . Secondary Objective To explore potential effect Luna Rich X© Reliv Now© body weight adiposity . Hypotheses 1 . Eight-week supplementation formulate lunasin-enriched soy concentrate ( Luna Rich X© ) adult risk cardiovascular disease improve serum lipid profile reduce inflammatory parameter . 2 . Eight-week supplementation formulate soy-based powder ( Reliv Now ) plus Luna Rich X adult risk cardiovascular disease improve serum lipid profile reduce inflammatory parameter . Study Protocol Recruitment Subjects Subjects recruit out-patient clinic near Loma Linda University . In collaboration medical personnel Family Internal Medicine clinic Loma Linda University Beaver Medical Group , interested clients/patients refer study . Potential subject inform study physician , nurse clinic personnel give flyer . Individuals make decision whether participate study . The clients/patients interested participate study contact investigator via provide phone number . A dedicated telephone line webpage provide additional information interested individual mean screen subject study personnel . Potential subject first screen study personnel , direct clinical laboratory Loma Linda University determination biochemical parameter eligibility study determine . Dietary Interventions - Luna Rich X© : 500 mg/ day 4 pill lunasin-enriched soy protein concentrate - Reliv Now : 19 gram powder/day , subject mix consume daily water beverage commonly drink . - Control : Placebo pill contain starch ( provide Reliv International , Inc . )</detailed_description>
	<criteria>1 . Men woman 3575 year age , high risk cardiovascular disease , i.e . 2 risk factor : Present tobacco smoker Arterial hypertension ( BP ≥140/90 mm Hg treatment ) LDLcholesterol ≥130 mg/dl HDLcholesterol ≤ 40 mg/dl Triglycerides ≥150 mg/dl Fasting blood glucose ≥110 mg/dl Overweight obesity ( BMI ≥ 25 kg/m2 ) Family history premature heart disease 1 . Uncontrolled renal/hepatic/endocrine disease 2 . Abnormal blood chemistry profile 3 . Familial hypercholesterolemia genetic dyslipidaemia 4 . Intake lipidlowering drug dietary product include plant sterols/stanols 5 . High Framingham risk medical condition statin therapy consider necessary treat physician 6 . Hypersensitive allergic soy 7 . Alcohol drug addiction/abuse 8 . Diabetics 9 . Impossibility lack interest follow dietary intervention</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>